{"transactions":[{"id":3884712,"issuer":{"id":6900,"kind":"organization","name":"electroCore, Inc.","symbol":"ECOR"},"owners":[{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":1,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T19:23:07.000Z","date":"2018-06-21","kind":"purchase","acquired":true,"shares":166666,"price":15,"value":2499990.0,"ownership":{"direct":true},"balance_after":3346032,"source":{"system":"sec-edgar","filing":"0001104659-18-041862","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1547132/000110465918041862/a4.xml","form_type":"4"}},{"id":132854,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":2807,"kind":"organization","name":"Merck & Co., Inc.","position":1,"cik":"0000310158","reported_name":"Merck & Co., Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11928,"kind":"organization","name":"Merck Sharp & Dohme Corp.","position":2,"cik":"0000942443","reported_name":"Merck Sharp & Dohme Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":3,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-02-08T21:05:50.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":13120,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These amounts reflect the Issuer's recently announced and effectuated a 1 for 25 reverse stock split on January 17, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"These amounts reflect the Issuer's recently announced and effectuated a 1 for 25 reverse stock split on January 17, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These amounts reflect the Issuer's recently announced and effectuated a 1 for 25 reverse stock split on January 17, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These amounts reflect the Issuer's recently announced and effectuated a 1 for 25 reverse stock split on January 17, 2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by Merck Global Health Innovation Fund, LLC (\"MGHIF\"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. (\"MSD\"), which is a wholly owned subsidiary of Merck & Co., Inc. (\"Merck\").  MSD and Merck are indirect beneficial owners of the reported securities."}],"balance_after":13120,"derivative":{"exercise_price":19.5,"exercise_date":"2018-01-28","expiration_date":"2022-06-28","underlying":"Common Stock","underlying_shares":13120},"source":{"system":"sec-edgar","filing":"0000899243-18-003274","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000089924318003274/doc5.xml","form_type":"5"}},{"id":151545,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":2807,"kind":"organization","name":"Merck & Co., Inc.","position":1,"cik":"0000310158","reported_name":"Merck & Co., Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11928,"kind":"organization","name":"Merck Sharp & Dohme Corp.","position":2,"cik":"0000942443","reported_name":"Merck Sharp & Dohme Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":3,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2016-06-29T20:05:50.000Z","date":"2016-06-27","kind":"purchase","acquired":true,"shares":2050821,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were included within units (\"Units\") with each Unit consisting of one share of the Company's common stock, par value $0.01 per share (the \"Common Stock\") and (ii) a warrant to acquire 0.75 of one share of Common Stock for a purchase price of $1.14375 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by Merck Global Health Innovation Fund, LLC (\"MGHIF\"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. (\"MSD\"), which is a wholly owned subsidiary of Merck & Co., Inc. (\"Merck\").  MSD and Merck are indirect beneficial owners of the reported securities."}],"balance_after":2950821,"derivative":{"exercise_price":1.3125,"exercise_date":"2016-09-27","expiration_date":"2021-06-27","underlying":"Common Stock","underlying_shares":2050821},"source":{"system":"sec-edgar","filing":"0000899243-16-023850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000089924316023850/doc4.xml","form_type":"4"}},{"id":151544,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":2807,"kind":"organization","name":"Merck & Co., Inc.","position":1,"cik":"0000310158","reported_name":"Merck & Co., Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11928,"kind":"organization","name":"Merck Sharp & Dohme Corp.","position":2,"cik":"0000942443","reported_name":"Merck Sharp & Dohme Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":3,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-06-29T20:05:50.000Z","date":"2016-06-27","kind":"grant","acquired":true,"shares":2734427,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were included within units (\"Units\") with each Unit consisting of one share of the Company's common stock, par value $0.01 per share (the \"Common Stock\") and (ii) a warrant to acquire 0.75 of one share of Common Stock for a purchase price of $1.14375 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by Merck Global Health Innovation Fund, LLC (\"MGHIF\"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. (\"MSD\"), which is a wholly owned subsidiary of Merck & Co., Inc. (\"Merck\").  MSD and Merck are indirect beneficial owners of the reported securities."}],"balance_after":5413449,"source":{"system":"sec-edgar","filing":"0000899243-16-023850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000089924316023850/doc4.xml","form_type":"4"}},{"id":152357,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":2807,"kind":"organization","name":"Merck & Co., Inc.","position":1,"cik":"0000310158","reported_name":"Merck & Co., Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11928,"kind":"organization","name":"Merck Sharp & Dohme Corp.","position":2,"cik":"0000942443","reported_name":"Merck Sharp & Dohme Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":3,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock and Warrants (Obligation to buy Units)","published_at":"2016-05-24T20:41:15.000Z","date":"2016-05-19","kind":"purchase","acquired":true,"shares":2734427,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents future obligation of MGHIF to purchase additional Units for a purchase price of $1.14375 per Unit within 60 days and subject to stockholder consent and notice to stockholders of same (including the filing of Schedule 14C and the twenty day waiting period), pursuant to the Amended and Restated Securities Purchase Agreement entered into on May 18, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents future obligation of MGHIF to purchase additional Units for a purchase price of $1.14375 per Unit within 60 days and subject to stockholder consent and notice to stockholders of same (including the filing of Schedule 14C and the twenty day waiting period), pursuant to the Amended and Restated Securities Purchase Agreement entered into on May 18, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents future obligation of MGHIF to purchase additional Units for a purchase price of $1.14375 per Unit within 60 days and subject to stockholder consent and notice to stockholders of same (including the filing of Schedule 14C and the twenty day waiting period), pursuant to the Amended and Restated Securities Purchase Agreement entered into on May 18, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Merck Global Health Innovation Fund, LLC (\"MGHIF\"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. (\"MSD\"), which is a wholly owned subsidiary of Merck & Co., Inc. (\"Merck\").  MSD and Merck are indirect beneficial owners of the reported securities."}],"balance_after":5685248,"derivative":{"exercise_price":1.1438,"underlying":"Common Stock","underlying_shares":4785248},"source":{"system":"sec-edgar","filing":"0000899243-16-020819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/310158/000089924316020819/doc4.xml","form_type":"4"}},{"id":152356,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":2807,"kind":"organization","name":"Merck & Co., Inc.","position":1,"cik":"0000310158","reported_name":"Merck & Co., Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11928,"kind":"organization","name":"Merck Sharp & Dohme Corp.","position":2,"cik":"0000942443","reported_name":"Merck Sharp & Dohme Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":3,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2016-05-24T20:41:15.000Z","date":"2016-05-19","kind":"purchase","acquired":true,"shares":900000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within units (\"Units\") each Unit consisting of one share of the Company's common stock, par value $0.01 per share (the \"Common Stock\") and (ii) a warrant to acquire 0.75 of one share of Common Stock for a purchase price of $1.14375 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Merck Global Health Innovation Fund, LLC (\"MGHIF\"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. (\"MSD\"), which is a wholly owned subsidiary of Merck & Co., Inc. (\"Merck\").  MSD and Merck are indirect beneficial owners of the reported securities."}],"balance_after":900000,"derivative":{"exercise_price":1.3125,"exercise_date":"2016-08-17","expiration_date":"2021-05-19","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0000899243-16-020819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000089924316020819/doc4.xml","form_type":"4"}},{"id":152355,"issuer":{"id":9776,"kind":"organization","name":"CapForce Inc."},"owners":[{"id":2807,"kind":"organization","name":"Merck & Co., Inc.","position":1,"cik":"0000310158","reported_name":"Merck & Co., Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":11928,"kind":"organization","name":"Merck Sharp & Dohme Corp.","position":2,"cik":"0000942443","reported_name":"Merck Sharp & Dohme Corp.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":12193,"kind":"organization","name":"Merck Global Health Innovation Fund, LLC","position":3,"cik":"0001547132","reported_name":"Merck Global Health Innovation Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-05-24T20:41:15.000Z","date":"2016-05-19","kind":"grant","acquired":true,"shares":1200000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within units (\"Units\") each Unit consisting of one share of the Company's common stock, par value $0.01 per share (the \"Common Stock\") and (ii) a warrant to acquire 0.75 of one share of Common Stock for a purchase price of $1.14375 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned directly by Merck Global Health Innovation Fund, LLC (\"MGHIF\"), which is a wholly owned subsidiary of Merck Sharp & Dohme Corp. (\"MSD\"), which is a wholly owned subsidiary of Merck & Co., Inc. (\"Merck\").  MSD and Merck are indirect beneficial owners of the reported securities."}],"balance_after":2679022,"source":{"system":"sec-edgar","filing":"0000899243-16-020819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/310158/000089924316020819/doc4.xml","form_type":"4"}}]}